Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

FDA grants rare pediatric disease designation to Kuros Biosciences' KUR-112

Oct. 21, 2016

Fujifilm Kyowa Kirin Biologics reports phase III results for adalimumab biosimilar FKB-327

Oct. 20, 2016

Two mutations at the same anticodon stem pair may cause different myopathic phenotypes

Oct. 20, 2016

Novel MYH7 mutation causes Laing distal myopathy

Oct. 19, 2016

Pfizer to begin shipping Inflectra next month

Oct. 18, 2016

DNAJB6 mutation is associated with myofibrillar myopathies

Oct. 17, 2016

Novel BICD2 mutations may cause SMALED2

Oct. 17, 2016

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Oct. 17, 2016

Novel SPEG gene mutation linked to centronuclear myopathy

Oct. 13, 2016

Meiji Seika opens phase I pharmacokinetic bioequivalence study of DMB-3113 and adalimumab in Japan

Oct. 11, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...